Yoshihiro Sowa Selected Research

spiruchostatin A

2/2018

FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Sowa Research Topics

Disease

41	Neoplasms (Cancer) 06/2020 - 05/2003
16	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2003
8	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2009
6	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 12/2005
6	Carcinoma (Carcinomatosis) 09/2020 - 11/2005
6	Osteosarcoma (Osteogenic Sarcoma) 08/2014 - 05/2005
5	Carcinogenesis 08/2015 - 05/2003
4	Peripheral Nerve Injuries 01/2021 - 07/2012
4	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 11/2004
3	Ovarian Neoplasms (Ovarian Cancer) 06/2020 - 01/2015
3	Seroma 12/2018 - 12/2016
2	Pain (Aches) 01/2022 - 10/2020
2	Chronic Pain 01/2022 - 10/2020
2	Lymphedema (Milroy Disease) 02/2021 - 06/2015
2	Atrophy 01/2021 - 02/2016
2	Cicatrix (Scar) 03/2020 - 01/2009
2	Necrosis 06/2019 - 09/2015
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 06/2012
2	Contracture 01/2017 - 06/2013
2	Thrombosis (Thrombus) 06/2016 - 03/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 01/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2015
2	Retinoblastoma (Glioblastoma, Retinal) 01/2015 - 02/2013
1	Obesity 01/2022
1	Postoperative Pain 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Insulin Resistance 01/2022
1	Skin Ulcer 03/2021
1	Disease Progression 03/2021
1	Adenocarcinoma of Lung 01/2020
1	Empyema 01/2020
1	Triple Negative Breast Neoplasms 08/2018

Drug/Important Bio-Agent (IBA)

12	Histone Deacetylase InhibitorsIBA 01/2020 - 05/2003
8	Histone Deacetylases (Histone Deacetylase)IBA 08/2018 - 05/2006
7	Pharmaceutical PreparationsIBA 01/2022 - 03/2008
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
7	LigandsIBA 01/2015 - 09/2006
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2020 - 08/2010
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 09/2006
5	Fluorouracil (Carac)FDA LinkGeneric 09/2017 - 05/2008
5	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2012 - 09/2005
4	diclofenac hydroxyethylpyrrolidine (DIEP)FDA Link 01/2022 - 06/2019
4	Retinoblastoma ProteinIBA 01/2018 - 02/2013
3	RO5126766IBA 06/2020 - 07/2013
3	Histones (Histone)IBA 01/2018 - 03/2008
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2016 - 03/2012
3	MicroRNAs (MicroRNA)IBA 01/2016 - 12/2012
3	AlkaloidsIBA 01/2015 - 03/2006
3	CaspasesIBA 01/2015 - 07/2006
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2021 - 01/2020
2	YM753 compoundIBA 08/2018 - 02/2018
2	Mevalonic Acid (Mevalonate)IBA 04/2018 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 02/2018 - 01/2015
2	Lysine (L-Lysine)FDA Link 01/2018 - 12/2016
2	Capsules (Microcapsules)IBA 01/2017 - 01/2016
2	brassininIBA 03/2016 - 03/2012
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 02/2016 - 05/2012
2	Hormones (Hormone)IBA 02/2016 - 05/2012
2	Orlistat (Xenical)FDA Link 02/2016 - 05/2012
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 08/2014 - 04/2010
2	Antineoplastic Agents (Antineoplastics)IBA 06/2013 - 05/2008
2	trametinibIBA 06/2013 - 07/2011
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 06/2013 - 12/2012
2	FlavonoidsIBA 01/2013 - 01/2005
2	ApigeninIBA 01/2013 - 01/2005
2	N- (3- (5- (4- bromo- 2- fluorophenylamino)- 3- cyclopropyl- 8- methyl- 2,4,7- trioxo- 3,4,7,8- tetrahydro- 2H- pyrido(2,3- d)pyrimidin- 1- yl)phenyl)methanesulfonamideIBA 08/2010 - 11/2007
2	sulforaphaneIBA 11/2007 - 09/2006
2	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2007 - 11/2003
1	fucoxanthinolIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Rosiglitazone (Avandia)FDA Link 01/2022
1	MelatoninIBA 01/2022
1	Inosine Monophosphate (IMP)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	DiterpenesIBA 02/2021
1	Thymidylate SynthaseIBA 02/2021
1	Phosphotransferases (Kinase)IBA 06/2020
1	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 06/2020
1	tyrosine receptor (receptor, tyrosine)IBA 06/2020
1	amrubicinIBA 01/2020
1	SurvivinIBA 08/2018
1	eribulin FDA Link 08/2018
1	TNF-Related Apoptosis-Inducing LigandIBA 04/2018

Therapy/Procedure

18	Therapeutics 01/2021 - 05/2003
11	Mammaplasty (Breast Reconstruction) 01/2022 - 09/2015
5	Drug Therapy (Chemotherapy) 02/2018 - 05/2003
4	Transplantation 01/2021 - 07/2012
3	Perforator Flap 01/2022 - 03/2020
3	Mastectomy (Mammectomy) 01/2022 - 09/2015
3	Length of Stay 12/2018 - 12/2016
3	Free Tissue Flaps 08/2017 - 03/2013
3	Chemoprevention 11/2013 - 05/2003
2	Simple Mastectomy 10/2020 - 01/2017
1	Operative Surgical Procedures 01/2022
1	Tissue Expansion Devices (Tissue Expander) 10/2020
1	Mandibular Osteotomy 09/2020
1	Intravenous Injections 01/2020
1	Thoracoplasty 01/2020
1	Electrocoagulation (Electrocautery) 12/2018